An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance

Published:2009-08 Issue:8 Volume:8 Page:2152-2162
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Mitra Doyel,Brumlik Michael J.,Okamgba Stella U.,Zhu Yun,Duplessis Tamika T.,Parvani Jenny G.,Lesko Samuel M.,Brogi Edi,Jones Frank E.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing;Pharmacology & Therapeutics;2024-09

2. Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer;Cancers;2024-07-24

3. Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer;CHINESE J CANCER RES;2024

4. miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review;Biochemistry and Biophysics Reports;2024-03

5. Resistance of HER2-expressing breast cancer patients treated with trastuzumab: Underlying mechanisms of resistance and reversals;Overcoming Cancers Resistant to HER-2 Antibodies;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP